dividends
NYSE · IBD
Inspire Corporate Bond Impact ESG ETF
Financial Services · Asset Management - Bonds
$23.55
Down-$0.02 (-0.08%)
Updated Aug 31, 2026, 11:10 PM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 450.75M
- P/E ratio
- —
- Dividend yield
- 4.28%
- 52-week range
- $22.94 – $24.78
- Volume
- 85.61K
- Avg. volume
- 60.58K
Price performance
IBD price history
1M range · 20 trading sessions · Daily adjusted prices
IBD closed at $23.55 after 20 trading sessions, down 0.30% for the selected period.
- Last close
- $23.55
- Period change
- -0.30%
- Period low
- $23.55
- Period high
- $23.69
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $23.69 | $23.69 | $23.51 | $23.55 | 85.61K |
| Aug 27, 2026 | $23.63 | $23.70 | $23.5397 | $23.62 | 70.27K |
| Aug 26, 2026 | $23.69 | $23.69 | $23.585 | $23.6384 | 76.91K |
| Aug 25, 2026 | $23.59 | $23.72 | $23.59 | $23.69 | 76.13K |
| Aug 24, 2026 | $23.58 | $23.6893 | $23.58 | $23.64 | 42.42K |
| Aug 21, 2026 | $23.67 | $23.71 | $23.5952 | $23.64 | 87.51K |
| Aug 20, 2026 | $23.65 | $23.6966 | $23.63 | $23.66 | 56.9K |
| Aug 19, 2026 | $23.75 | $23.759 | $23.6503 | $23.67 | 108.98K |
| Aug 18, 2026 | $23.57 | $23.67 | $23.57 | $23.66 | 184.44K |
| Aug 17, 2026 | $23.62 | $23.719 | $23.62 | $23.64 | 67.28K |
| Aug 14, 2026 | $23.68 | $23.725 | $23.64 | $23.64 | 43.96K |
| Aug 13, 2026 | $23.63 | $23.75 | $23.63 | $23.68 | 55.31K |
| Aug 12, 2026 | $23.75 | $23.75 | $23.6154 | $23.645 | 25.31K |
| Aug 11, 2026 | $23.75 | $23.75 | $23.581 | $23.625 | 64.78K |
| Aug 10, 2026 | $23.58 | $23.67 | $23.52 | $23.63 | 74.29K |
| Aug 7, 2026 | $23.65 | $23.73 | $23.62 | $23.62 | 143.34K |
| Aug 6, 2026 | $23.62 | $23.6953 | $23.5201 | $23.64 | 81.44K |
| Aug 5, 2026 | $23.68 | $23.70 | $23.60 | $23.69 | 117.19K |
| Aug 4, 2026 | $23.59 | $23.9147 | $23.59 | $23.68 | 57.52K |
| Aug 3, 2026 | $23.57 | $23.75 | $23.57 | $23.62 | 92.35K |
Latest IBD news
The latest Smart Investors Daily articles mentioning IBD.
Stock researchResearch & News · Competitors
Loading stock research…